G. Simonneau, M. A. Gatzoulis, I. Adatia, D. Celermajer, C. Denton et al., Updated clinical classification of pulmonary hypertension

, Turk Kardiyol Dern Ars, vol.42, issue.1, pp.45-54, 2014.

E. Stacher, B. B. Graham, J. M. Hunt, A. Gandjeva, S. D. Groshong et al., Modern age pathology of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, pp.261-272, 2012.

R. M. Tuder, Pulmonary vascular remodeling in pulmonary hypertension, Cell Tissue Res, vol.367, pp.643-649, 2017.

R. M. Tuder, B. Groves, D. B. Badesch, and N. F. Voelkel, Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Am J Pathol, vol.144, pp.275-285, 1994.

A. Bourgeois, J. Omura, K. Habbout, S. Bonnet, and O. Boucherat, Pulmonary arterial hypertension: new pathophysiological insights and emerging therapeutic targets, Int J Biochem Cell Biol, vol.104, pp.9-13, 2018.

B. Ranchoux, L. D. Harvey, R. J. Ayon, A. Babicheva, S. Bonnet et al., Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape, Grover Conference Series). Pulm Circ, vol.8, p.2045893217752912, 2017.

M. S. Siobal, Pulmonary vasodilators, Respir Care, vol.52, pp.885-899, 2007.

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of pulmonary arterial hypertension, N Engl J Med, vol.351, pp.1425-1436, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01455600

A. Shimony, M. J. Eisenberg, L. G. Rudski, R. Schlesinger, J. Afilalo et al., Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension, Am J Cardiol, vol.108, pp.460-464, 2011.

V. Anand, S. S. Roy, S. L. Archer, E. K. Weir, S. K. Garg et al., Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the nationwide inpatient sample database from, JAMA Cardiol, vol.1, pp.1021-1029, 2001.

G. Ruffenach, S. Chabot, V. F. Tanguay, A. Courboulin, O. Boucherat et al., Role for Runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.194, pp.1273-1285, 2016.

J. Meloche, M. C. Lampron, V. Nadeau, M. Maltais, F. Potus et al., Implication of inflammation and epigenetic readers in coronary artery remodeling in patients with pulmonary arterial hypertension, Arterioscler Thromb Vasc Biol, vol.37, pp.1513-1523, 2017.

D. E. Van-der-feen, K. Kurakula, E. Tremblay, O. Boucherat, G. Bossers et al., Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.200, pp.910-920, 2019.

W. Dai, W. Duan, F. J. Alfaro, A. Gavrieli, F. Kourtelidis et al., The resting perfusion pattern associates with functional decline in type 2 diabetes, Neurobiol Aging, vol.60, pp.192-202, 2017.

S. Malenfant, P. Brassard, M. Paquette, L. Blanc, O. Chouinard et al., Compromised cerebrovascular regulation and cerebral oxygenation in pulmonary arterial hypertension, J Am Heart Assoc, vol.6, p.6126, 2017.

E. Treptow, M. F. Oliveira, A. Soares, R. P. Ramos, L. Medina et al., Cerebral microvascular blood flow and CO 2 reactivity in pulmonary arterial hypertension, Respir Physiol Neurobiol, vol.233, pp.60-65, 2016.

M. Minic, J. T. Granton, and C. M. Ryan, Sleep disordered breathing in group 1 pulmonary arterial hypertension, J Clin Sleep Med, vol.10, pp.277-283, 2014.

R. Hughes, J. Tong, C. Oates, J. Lordan, and P. A. Corris, Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension, Chest, vol.128, issue.6, p.617, 2005.

N. Peled, D. Shitrit, B. D. Fox, D. Shlomi, A. Amital et al., Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension, J Rheumatol, vol.36, pp.970-975, 2009.

B. Wolff, S. Lodziewski, T. Bollmann, C. F. Opitz, and R. Ewert, Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost, Am Heart J, vol.153, pp.1-7, 2007.

S. Said and G. T. Hernandez, The link between chronic kidney disease and cardiovascular disease, J Nephropathol, vol.3, pp.99-104, 2014.

F. Husain-syed, P. A. Mccullough, H. W. Birk, M. Renker, A. Brocca et al., Cardio-pulmonary-renal interactions: a multidisciplinary approach, J Am Coll Cardiol, vol.65, pp.2433-2448, 2015.

N. P. Nickel, J. M. O'leary, E. L. Brittain, J. P. Fessel, R. T. Zamanian et al., Kidney dysfunction in patients with pulmonary arterial hypertension, Pulm Circ, vol.7, pp.38-54, 2017.

J. M. O'leary, T. Assad, A. Hemnes, M. Xu, Q. Wells et al., Pulmonary hypertension and chronic kidney disease: invasive hemodynamic etiology and outcomes in a large electronic medical recordbased cohort

, J Am Coll Cardiol, vol.67, issue.13, p.2048, 2016.

M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, vol.173, pp.1023-1030, 2006.

S. J. Shah, T. Thenappan, S. Rich, L. Tian, S. L. Archer et al., Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension, Circulation, vol.117, pp.2475-2483, 2008.

T. Deckert, B. Feldt-rasmussen, K. Borch-johnsen, T. Jensen, and A. Kofoed-enevoldsen, Albuminuria reflects widespread vascular damage: the Steno hypothesis, Diabetologia, vol.32, pp.219-226, 1989.

F. Tanaka, R. Komi, S. Makita, T. Onoda, K. Tanno et al., Iwate-Kenco Study Group. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals, J Hypertens, vol.34, p.512, 2016.

J. Arnlöv, J. C. Evans, J. B. Meigs, T. J. Wang, C. S. Fox et al., Lowgrade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study, Circulation, vol.112, pp.969-975, 2005.

N. P. Nickel, J. De, V. A. Perez, R. T. Zamanian, J. P. Fessel et al., Low-grade albuminuria in pulmonary arterial hypertension, Pulm Circ, vol.9, p.2045894018824564, 2019.

H. Ho, C. Y. Cheung, C. Sabanayagam, W. Yip, M. K. Ikram et al., Retinopathy signs improved prediction and reclassification of cardiovascular disease risk in diabetes: a prospective cohort study, Sci Rep, vol.7, p.41492, 2017.

M. Watanabe, S. Makino, and H. Obata, Bilaterally dilated episcleral vessels in patients with heritable pulmonary arterial hypertension, J Gen Fam Med, vol.18, pp.464-465, 2017.

A. C. Chyou, B. Klein, R. Klein, R. G. Barr, M. F. Cotch et al., Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies, Pulm Circ, vol.9, p.2045894018819781, 2018.

V. Riccieri, M. Vasile, N. Iannace, K. Stefanantoni, I. Sciarra et al., Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study, Rheumatology (Oxford), vol.52, pp.1525-1528, 2013.

A. Corrado, M. Correale, N. Mansueto, I. Monaco, A. Carriero et al., Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension, Microvasc Res, vol.114, pp.46-51, 2017.

H. M. Hofstee, A. Vonk-noordegraaf, A. E. Voskuyl, B. A. Dijkmans, P. E. Postmus et al., Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis, Ann Rheum Dis, vol.68, pp.191-195, 2009.

L. Dababneh, F. Cikach, L. Alkukhun, R. A. Dweik, and A. R. Tonelli, Sublingual microcirculation in pulmonary arterial hypertension, Ann Am Thorac Soc, vol.11, pp.504-512, 2014.

J. Weatherald, A. Huertas, A. Boucly, C. Guignabert, Y. Taniguchi et al., Association between BMI and obesity with survival in pulmonary arterial hypertension, Chest, vol.154, pp.872-881, 2018.

L. Benson, E. L. Brittain, M. E. Pugh, E. D. Austin, K. Fox et al., Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension, Pulm Circ, vol.4, pp.311-318, 2014.

R. T. Zamanian, G. Hansmann, S. Snook, D. Lilienfeld, K. M. Rappaport et al., Insulin resistance in pulmonary arterial hypertension, Eur Respir J, vol.33, pp.318-324, 2009.

J. West, K. D. Niswender, J. A. Johnson, M. E. Pugh, L. Gleaves et al., A potential role for insulin resistance in experimental pulmonary hypertension, Eur Respir J, vol.41, pp.861-871, 2013.

G. Hansmann, R. A. Wagner, S. Schellong, V. A. Perez, T. Urashima et al., Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-g activation, Circulation, vol.115, pp.1275-1284, 2007.

E. Legchenko, P. Chouvarine, P. Borchert, A. Fernandez-gonzalez, E. Snay et al., PPARg agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation, Sci Transl Med, vol.10, p.303, 2018.

M. Cnop, J. C. Hannaert, A. Hoorens, D. L. Eizirik, and D. G. Pipeleers, Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation, Diabetes, vol.50, pp.1771-1777, 2001.

E. L. Brittain, M. Talati, J. P. Fessel, H. Zhu, N. Penner et al., Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension, Circulation, vol.133, pp.1936-1944, 2016.

A. R. Hemnes, J. M. Luther, C. J. Rhodes, J. P. Burgess, J. Carlson et al., Human PAH is characterized by a pattern of lipid-related insulin resistance, JCI Insight, vol.4, p.123611, 2019.

P. Scicchitano, I. Dentamaro, F. Tunzi, G. Ricci, S. Carbonara et al., Pulmonary hypertension in thyroid diseases, Endocrine, vol.54, pp.578-587, 2016.

C. W. Siu, X. H. Zhang, C. Yung, A. W. Kung, C. P. Lau et al., Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study, J Clin Endocrinol Metab, vol.92, pp.1736-1742, 2007.

D. Giovambattista and R. , Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure, Cardiovasc Ultrasound, vol.6, p.29, 2008.

D. B. Badesch, G. E. Raskob, C. G. Elliott, A. M. Krichman, H. W. Farber et al., Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry, Chest, vol.137, pp.376-387, 2010.

J. H. Li, R. E. Safford, J. F. Aduen, M. G. Heckman, J. E. Crook et al., Pulmonary hypertension and thyroid disease, Chest, vol.132, pp.793-797, 2007.

M. Udovcic, R. H. Pena, B. Patham, L. Tabatabai, and A. Kansara, Hypothyroidism and the heart, Methodist DeBakey Cardiovasc J, vol.13, pp.55-59, 2017.

M. J. Richter, N. Sommer, R. Schermuly, B. Grimminger, W. Seeger et al., The prognostic impact of thyroid function in pulmonary hypertension, J Heart Lung Transplant, vol.35, pp.1427-1434, 2016.

G. Simonneau, D. Montani, D. S. Celermajer, C. P. Denton, M. A. Gatzoulis et al., Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, p.1801913, 2019.

C. S. Stump, E. J. Henriksen, Y. Wei, and J. R. Sowers, The metabolic syndrome: role of skeletal muscle metabolism, Ann Med, vol.38, pp.389-402, 2006.

M. H. Laughlin, R. E. Klabunde, M. D. Delp, and R. B. Armstrong, Effects of dipyridamole on muscle blood flow in exercising miniature swine, Am J Physiol, vol.257, pp.1507-1515, 1989.

E. A. Aaron, K. C. Seow, B. D. Johnson, and J. A. Dempsey, Oxygen cost of exercise hyperpnea: implications for performance, J Appl Physiol, vol.72, pp.1818-1825, 1985.

A. Chaouat, O. Sitbon, M. Mercy, R. Ponçot-mongars, S. Provencher et al., Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension, Eur Respir J, vol.44, pp.704-713, 2014.

S. Provencher, P. Hervé, O. Sitbon, M. Humbert, G. Simonneau et al., Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension, Eur Respir J, vol.32, pp.393-398, 2008.

R. Bauer, C. Dehnert, P. Schoene, A. Filusch, P. Bärtsch et al., Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension, Respir Med, vol.101, pp.2366-2369, 2007.

V. Mainguy, F. Maltais, D. Saey, P. Gagnon, S. Martel et al., Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension, Thorax, vol.65, pp.113-117, 2010.

S. Malenfant, F. Potus, F. Fournier, S. Breuils-bonnet, A. Pflieger et al., Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension, J Mol Med (Berl), vol.93, pp.573-584, 2015.

A. P. Breda, A. L. Pereira-de-albuquerque, C. Jardim, L. K. Morinaga, M. M. Suesada et al., Skeletal muscle abnormalities in pulmonary arterial hypertension, PLoS One, vol.9, p.114101, 2014.

F. Potus, S. Malenfant, C. Graydon, V. Mainguy, . Tremblayè et al., Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.190, pp.318-328, 2014.

F. J. Meyer, D. Lossnitzer, A. V. Kristen, A. M. Schoene, W. Kübler et al., Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.25, pp.125-130, 2005.

F. S. De-man, H. W. Van-hees, M. L. Handoko, H. W. Niessen, I. Schalij et al., Diaphragm muscle fiber weakness in pulmonary hypertension, Am J Respir Crit Care Med, vol.183, pp.1411-1418, 2011.

S. Malenfant, F. Potus, V. Mainguy, E. Leblanc, M. Malenfant et al., Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension, Med Sci Sports Exerc, vol.47, pp.2273-2282, 2015.

E. Manders, G. Ruiter, H. J. Bogaard, G. J. Stienen, A. Vonk-noordegraaf et al., Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension, Eur Respir J, vol.45, pp.1737-1740, 2015.

S. Dimopoulos, G. Tzanis, C. Manetos, A. Tasoulis, A. Mpouchla et al., Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study, Respir Care, vol.58, pp.2134-2141, 2013.

S. Müller-mottet, F. F. Hildenbrand, S. Keusch, E. Hasler, M. Maggiorini et al., Effects of exercise and vasodilators on cerebral tissue oxygenation in pulmonary hypertension, Lung, vol.193, pp.113-120, 2015.

S. Sithamparanathan, M. C. Rocha, J. D. Parikh, K. A. Rygiel, G. Falkous et al., Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study, Pulm Circ, vol.8, p.2045894018768290, 2018.

G. D'antona, M. A. Pellegrino, R. Adami, R. Rossi, C. N. Carlizzi et al., The effect of ageing and immobilization on structure and function of human skeletal muscle fibres, J Physiol, vol.552, pp.499-511, 2003.

V. Mainguy, S. Provencher, F. Maltais, S. Malenfant, and D. Saey, Assessment of daily life physical activities in pulmonary arterial hypertension, PLoS One, vol.6, p.27993, 2011.

T. Becker-grünig, H. Klose, N. Ehlken, M. Lichtblau, C. Nagel et al., Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease, Int J Cardiol, vol.168, pp.375-381, 2013.

L. Chan, L. Chin, M. Kennedy, J. G. Woolstenhulme, S. D. Nathan et al., Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension, Chest, vol.143, pp.333-343, 2013.

D. Mereles, N. Ehlken, S. Kreuscher, S. Ghofrani, M. M. Hoeper et al., Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension, Circulation, vol.114, pp.1482-1489, 2006.

E. Grünig, C. Eichstaedt, J. A. Barberà, N. Benjamin, I. Blanco et al., ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension, Eur Respir J, vol.53, p.1800332, 2019.

M. E. Deffebach, N. B. Charan, S. Lakshminarayan, and J. Butler, The bronchial circulation: small, but a vital attribute of the lung, Am Rev Respir Dis, vol.135, pp.463-481, 1987.

S. F. Boushy, L. B. North, and J. A. Trice, The bronchial arteries in chronic obstructive pulmonary disease, Am J Med, vol.46, pp.506-515, 1969.

C. Grosse and A. Grosse, CT findings in diseases associated with pulmonary hypertension: a current review, Radiographics, vol.30, pp.1753-1777, 2010.

D. Tio, E. Leter, B. Boerrigter, A. Boonstra, A. Vonk-noordegraaf et al., Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension, PLoS One, vol.8, p.78132, 2013.

M. R. Ghigna, C. Guignabert, D. Montani, B. Girerd, X. Jaïs et al., BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension, Eur Respir J, vol.48, pp.1668-1681, 2016.

C. Galambos, S. Sims-lucas, S. H. Abman, and C. D. Cool, Intrapulmonary bronchopulmonary anastomoses and plexiform lesions in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.193, pp.574-576, 2016.

M. Rabinovitch, C. Guignabert, M. Humbert, and M. R. Nicolls, Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ Res, vol.115, pp.165-175, 2014.

L. C. Price, S. J. Wort, F. Perros, P. Dorfmüller, A. Huertas et al., Inflammation in pulmonary arterial hypertension, Chest, vol.141, pp.210-221, 2012.

A. J. Sweatt, H. K. Hedlin, V. Balasubramanian, A. Hsi, L. K. Blum et al., Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension, Circ Res, vol.124, pp.904-919, 2019.

M. Valentova, S. Von-haehling, J. Bauditz, W. Doehner, N. Ebner et al., Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure, Eur Heart J, vol.37, pp.1684-1691, 2016.

B. Ranchoux, A. Bigorgne, A. Hautefort, B. Girerd, O. Sitbon et al., Gut-lung connection in pulmonary arterial hypertension, Am J Respir Cell Mol Biol, vol.56, pp.402-405, 2017.

T. Sobko, C. I. Reinders, E. Jansson, E. Norin, T. Midtvedt et al., Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite, Nitric Oxide, vol.13, pp.272-278, 2005.

K. Y. Stokes, T. R. Dugas, Y. Tang, H. Garg, E. Guidry et al., Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction, Am J Physiol Heart Circ Physiol, vol.296, pp.1281-1288, 2009.

M. Delmastro-greenwood, K. S. Hughan, D. A. Vitturi, S. R. Salvatore, G. Grimes et al., Nitrite and nitrate-dependent generation of antiinflammatory fatty acid nitroalkenes, Free Radic Biol Med, vol.89, pp.333-341, 2015.